135 related articles for article (PubMed ID: 30890370)
1. TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.
Amalia R; Abdelaziz M; Puteri MU; Hwang J; Anwar F; Watanabe Y; Kato M
Cell Signal; 2019 Jul; 59():24-33. PubMed ID: 30890370
[TBL] [Abstract][Full Text] [Related]
2. Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene.
Nakano N; Itoh S; Watanabe Y; Maeyama K; Itoh F; Kato M
J Biol Chem; 2010 Dec; 285(49):38023-33. PubMed ID: 20889500
[TBL] [Abstract][Full Text] [Related]
3. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
4. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Saikumar P
Genes Cancer; 2014 Sep; 5(9-10):320-36. PubMed ID: 25352949
[TBL] [Abstract][Full Text] [Related]
5. Cooperative induction of transmembrane prostate androgen induced protein TMEPAI/PMEPA1 by transforming growth factor-β and epidermal growth factor signaling.
Azami S; Vo Nguyen TT; Watanabe Y; Kato M
Biochem Biophys Res Commun; 2015 Jan; 456(2):580-5. PubMed ID: 25482449
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
7. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
9. PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells.
Puteri MU; Watanabe Y; Wardhani BWK; Amalia R; Abdelaziz M; Kato M
Genes Cells; 2020 Jun; 25(6):375-390. PubMed ID: 32181976
[TBL] [Abstract][Full Text] [Related]
10. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
11. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
12. [Effects of NGX6 on the transcriptional activation of beta-catenin/TCF/LEF in Wnt/beta-catenin signal pathway].
Liu F; Shen SR; Li HT; Wang XY; Peng Y; Liao MT; Guo Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):985-91. PubMed ID: 18182714
[TBL] [Abstract][Full Text] [Related]
13. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
14. LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation.
Zhang J; Zhang X; Zhang L; Zhou F; van Dinther M; Ten Dijke P
J Bone Miner Res; 2012 Oct; 27(10):2065-74. PubMed ID: 22589174
[TBL] [Abstract][Full Text] [Related]
15. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
17. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
[TBL] [Abstract][Full Text] [Related]
18. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
19. WNT3a Signaling Inhibits Aromatase Expression in Breast Adipose Fibroblasts-A Possible Mechanism Supporting the Loss of Estrogen Responsiveness of Triple-Negative Breast Cancers.
Kaiser A; Eiselt G; Bechler J; Huber O; Schmidt M
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902090
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
